
Lilly, Novo Nordisk seek insurance coverage in Korea for diabetes drugs Mounjaro and Ozempic
In Korea, Eli Lilly and Novo Nordisk are pushing for national health insurance coverage for their diabetes drugs Mounjaro and Ozempic, which have demonstrated benefits in blood sugar control and weight loss. Korea Biomedical Review has learned on Friday …